Shawn Leland
Director/Board Member bei Fore Biotherapeutics, Inc.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Shawn M.
Leland was the founder of Elevation Oncology, Inc. (founded in 2019) where he held the title of President, Chief Executive Officer & Director from 2020 to 2023.
He is currently working as a Director at Fore Biotherapeutics, Inc. since 2023.
Previously, Dr. Leland worked as a Senior Director-Corporate Development & Strategy at Argos Therapeutics, Inc. from 2013 to 2017 and as a Vice President-Business Development at Verastem, Inc. from 2017 to 2019.
He obtained his undergraduate degree from Albany College of Pharmacy & Health Sciences.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ELEVATION ONCOLOGY, INC.
1,74% | 31.03.2023 | 846 826 ( 1,74% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Shawn Leland
| Unternehmen | Position | Beginn |
|---|---|---|
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Director/Board Member | 01.09.2023 |
Ehemalige bekannte Positionen von Shawn Leland
| Unternehmen | Position | Ende |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Founder | 05.01.2023 |
| VERASTEM, INC. | Corporate Officer/Principal | 01.08.2019 |
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01.09.2017 |
Ausbildung von Shawn Leland
| Albany College of Pharmacy & Health Sciences | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VERASTEM, INC. | Health Technology |
| ELEVATION ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
